Analysis of response of severe eosinophilic asthmatic patients to benralizumab.
Miralles-López JC, Andújar-Espinosa R, Bravo-Gutiérrez FJ, Castilla-Martínez M, Flores-Martín I, Alemany-Francés ML, Pajarón-Fernández MJ, Mora-González A, Cabrejos-Perotti S, El-Molaka Z, Meseguer-Arce J, Avilés-Inglés MJ, Valverde-Molina J, Pérez-Fernández V; RE-ASGRAMUR Group.
Miralles-López JC, et al. Among authors: pajaron fernandez mj.
Allergol Immunopathol (Madr). 2022 Nov 1;50(6):163-168. doi: 10.15586/aei.v50i6.704. eCollection 2022.
Allergol Immunopathol (Madr). 2022.
PMID: 36335460